Jonathan Gootenberg

This inventor holds 6 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Massachusetts Institute of Technology, The Broad Institute, Inc., Harvard College. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan Gootenberg. Retrieved from https://idiyas.com/inventor/jonathan-gootenberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 2)

% Patents Active = 83.3

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 5.0

ph-index = 1

Company Filing History:

5 out of 8,586

Massachusetts Institute of Technology

patents

5 out of 486

The Broad Institute, Inc.

where one patent can have more than one assignee

Years Active: 2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760297 - CRISPR/Cas-cytidine deaminase based compositions, systems, and methods for targeted nucleic acid editing (2026-10-13),

2. 12655403 - Systems, methods, and compositions for targeted nucleic acid editing (2026-06-16),

3. 12644111 - CRISPR enzymes and systems (2026-06-02),

4. 12630867 - Devices for CRISPR effector system based diagnostics (2026-05-19),

5. 12559786 - CRISPR/Cas and transposase based amplification compositions, systems and methods (2026-02-24),

6. 12522863 - Crispr effector system based coronavirus diagnostics (2026-01-13),

Title: Jonathan Gootenberg: Innovator in CRISPR Diagnostics

Introduction

Jonathan Gootenberg is a prominent inventor based in Cambridge, MA (US). He is known for his significant contributions to the field of biotechnology, particularly in the development of diagnostic systems utilizing CRISPR technology. His innovative work has the potential to revolutionize the way we detect and respond to viral infections.

Latest Patents

Gootenberg holds a patent for a "Crispr effector system based coronavirus diagnostics." This patent encompasses systems and methods for rapid diagnostics related to the use of CRISPR effector systems and optimized guide sequences for the detection of coronavirus. It includes multiplex lateral flow diagnostic devices and methods of use, showcasing his commitment to advancing medical diagnostics.

Career Highlights

Throughout his career, Gootenberg has worked with esteemed institutions such as the Broad Institute, Inc. and the Massachusetts Institute of Technology. His experience in these leading research environments has allowed him to collaborate with some of the brightest minds in the field.

Collaborations

One of his notable collaborators is Feng Zhang, a fellow innovator in the CRISPR space. Their partnership has contributed to the advancement of CRISPR technology and its applications in diagnostics.

Conclusion

Jonathan Gootenberg's work in CRISPR diagnostics exemplifies the intersection of innovation and healthcare. His contributions are paving the way for more effective and rapid diagnostic methods, which could have a lasting impact on public health.

Profile summary based on public USPTO records.